DURECT Corp
NASDAQ:DRRX

Watchlist Manager
DURECT Corp Logo
DURECT Corp
NASDAQ:DRRX
Watchlist
Price: 1.26 USD -2.33% Market Closed
Market Cap: 39.1m USD
Have any thoughts about
DURECT Corp?
Write Note

P/E
Price to Earnings

-2.5
Current
-2.9
Median
22.3
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-2.5
=
Market Cap
39.1m USD
/
Net Income
-15.8m USD
All Countries
Close
Market Cap P/E
US
DURECT Corp
NASDAQ:DRRX
39.1m USD -2.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -5 347 888.9
US
Eli Lilly and Co
NYSE:LLY
871.6B USD 118.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
DK
Novo Nordisk A/S
CSE:NOVO B
3.6T DKK 40.1
US
Johnson & Johnson
NYSE:JNJ
395.9B USD 27
US
Merck & Co Inc
NYSE:MRK
278.3B USD 20.3
CH
Roche Holding AG
SIX:ROG
216.5B CHF 18.8
UK
AstraZeneca PLC
NASDAQ:AZN
241.9B USD 37.6
CH
Novartis AG
SIX:NOVN
197.5B CHF 14.1
US
Pfizer Inc
NYSE:PFE
165.9B USD -63.9
Earnings Growth
US
DURECT Corp
NASDAQ:DRRX
Average P/E: 39.5
Negative Multiple: -2.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
118.7
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
40.1
90%
US
Johnson & Johnson
NYSE:JNJ
27
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
CH
Roche Holding AG
SIX:ROG
18.8
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.6
175%
CH
Novartis AG
SIX:NOVN
14.1
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -63.9
712%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-1.4
2-Years Forward
P/E
-0.9
3-Years Forward
P/E
-1.1

See Also

Discover More